$6.76+0.01 (+0.15%)
At close: Nov 20, 2026, 4:00 PM ET· Nasdaq · USD
Avalo Therapeutics (AVTX) Stock Splits
Splits, dividend moves, buybacks and structural changes on file for AVTX, and what each one says about how management treats you, the shareholder.
Sources Dividend announcements and company filings Dividends and filingsHow we compute thisNot investment advice
•
Management posture
Returns cash, still building a record
Management returns cash through dividends and/or buybacks, but the track record is shorter or less consistent than a seasoned compounder's. Judge each action on its own coverage.
Annual raise streak
—
no dividend on fileBuyback · FY25
$462,000.00
repurchased, latest FYLast split
1:240
Dec 29, 2023 · reverseDelist / distress
None
no red flags on fileAction history
· 4 on file · newest first✓
Reads are interpretationsEach action's read is Tenet's plain-English interpretation of the action type: a starting point, not investment advice.
Reads are Tenet's plain-English interpretation of each action type, a starting point, not investment advice.
Common questions
When did Avalo Therapeutics last split its stock?
Avalo Therapeutics' last split was 1:240 on Dec 29, 2023.
How much stock did Avalo Therapeutics buy back last fiscal year?
Avalo Therapeutics repurchased $462,000.00 of its own shares in fiscal 2025.

